Trademark Search in Canada

LDL-ADVANCE

View On IC.GC.CA

REGISTERED

on 22 Jun 2007

Last Applicant/ Owned by

SEKISUI DIAGNOSTICS LLC

31 New York AvenueFramingham, Massachusetts, 01701-9322

Serial Number

1220076 filed on 8^th Jun 2004

Registration Number

TMA690710 registered on 22^nd Jun 2007

Registration expiry Date

22^nd Jun 2032

Correspondent Address

CYNTHIA D. MASON

1000 Innovation Drive, Suite 500Kanata

ONTARIO

K2K3E7

LDL-ADVANCE

Trademark usage description

chemical reagents based on a selective detergent methodology, used for in vitro diagnostic purposes in respect to the quantitative determination of lo Read More

Classification Information

Class [001]
Chemical reagents based on a selective detergent methodology, used for IN VITRO diagnostic purposes in respect to the quantitative determination of low density lipoprotein fractions of cholesterol in serum.

Classification kind code

Mark Details

Serial Number

1220076

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 87 on 18^th Jun 2008	Rep for Service Changed
Submitted for opposition 55 on 22^nd Jun 2007	Registered
Submitted for opposition 50 on 28^th Jan 2005	Allowed
Submitted for opposition 51 on 28^th Jan 2005	Allowance Notice Sent
Submitted for opposition 42 on 10^th Nov 2004	Advertised
Submitted for opposition 26 on 8^th Oct 2004	Approved
Submitted for opposition 22 on 6^th Oct 2004	Search Recorded
Submitted for opposition 31 on 21^st Jun 2004	Formalized
Submitted for opposition 1 on 11^th Jun 2004	Created
Submitted for opposition 30 on 8^th Jun 2004	Filed

LDL-ADVANCE

Classification Information

Class [001]Chemical reagents based on a selective detergent methodology, used for IN VITRO diagnostic purposes in respect to the quantitative determination of low density lipoprotein fractions of cholesterol in serum.

Classification kind code

Mark Details

Serial Number

Mark Type

Legal History

Class [001]
Chemical reagents based on a selective detergent methodology, used for IN VITRO diagnostic purposes in respect to the quantitative determination of low density lipoprotein fractions of cholesterol in serum.